(2s)-2-amino-n-(1,2,3,4-tetrahydronaphthalen-2-yl)propanamide (CED0240310)

Record Information
Version1.0
Creation Date2026-08-28 01:38:54 UTC
Update Date2026-08-28 01:38:54 UTC
Accession NumberCHEM284470
Identification
Common Name(2s)-2-amino-n-(1,2,3,4-tetrahydronaphthalen-2-yl)propanamide
ClassSmall Molecule
Description
(2s)-2-amino-n-(1,2,3,4-tetrahydronaphthalen-2-yl)propanamide belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. This compound has the formula C13H18N2O and an average molecular weight of 218.29 g/mol. It is identified as being found in or released from two recorded sources, specifically amplifiers and electric hearing aids categorized under electrical and electronic equipment.
Contaminant TypeNot Available
Chemical Structure
MOLSDFPDBSMILESInChI
SynonymsNot Available
Chemical FormulaC13H18N2O
Average Molecular MassNot Available
Monoisotopic Mass218.142 g/mol
CAS Registry Number14329-69-2
IUPAC NameNot Available
Traditional NameNot Available
SMILESCC(C(=O)NC1CCC2=CC=CC=C2C1)N
InChI IdentifierInChI=1S/C13H18N2O/c1-9(14)13(16)15-12-7-6-10-4-2-3-5-11(10)8-12/h2-5,9,12H,6-8,14H2,1H3,(H,15,16)/t9-,12?/m0/s1
InChI KeyDSSRNNGLLCLIPR-QHGLUPRGSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
SpectraNot Available
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity Values
Toxicity ValueUnitValue RangeOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalReference
1453.0Log mg/kg[820:2600]RatLD50oralpredictedNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
505AmplifiersElectrical & Electronic EquipmentNot Available
516Electric Hearing AidsElectrical & Electronic EquipmentNot Available
631Anthraquinone DyesTextiles, leather & furnishingsNot Available
Pathways
0 pathways

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Click to view 3D structureSigma non-opioid intracellular receptor 1Q60492Cavia porcellusPredicted (SEA)161.771
Glutamate receptor ionotropic, NMDA 2B structureClick to view 3D structureGlutamate receptor ionotropic, NMDA 2BQ13224HumansPredicted (SEA)21.9535
Sigma non-opioid intracellular receptor 1 structureClick to view 3D structureSigma non-opioid intracellular receptor 1Q99720HumansPredicted (SEA)366.203
Click to view 3D structureMu-type opioid receptorP33535Rattus norvegicusPredicted (SEA)381.072
Click to view 3D structure5-hydroxytryptamine receptor 1AP19327Rattus norvegicusPredicted (SEA)513.104
Matrix metalloproteinase-9 structureClick to view 3D structureMatrix metalloproteinase-9P14780HumansPredicted (SEA)394.696
Click to view 3D structureDelta-type opioid receptorP33533Rattus norvegicusPredicted (SEA)333.662
Click to view 3D structureMu-type opioid receptorP97266Cavia porcellusPredicted (SEA)344.716
Click to view 3D structureDelta-type opioid receptorP32300Mus musculusPredicted (SEA)330.003
Mu-type opioid receptor structureClick to view 3D structureMu-type opioid receptorP35372HumansPredicted (SEA)693.247
Angiotensin-converting enzyme structureClick to view 3D structureAngiotensin-converting enzymeP12821HumansPredicted (SEA)190.186
Delta-type opioid receptor structureClick to view 3D structureDelta-type opioid receptorP41143HumansPredicted (SEA)586.672
E3 ubiquitin-protein ligase XIAP structureClick to view 3D structureE3 ubiquitin-protein ligase XIAPP98170HumansPredicted (SEA)38.5354
Click to view 3D structureSigma non-opioid intracellular receptor 1Q9R0C9Rattus norvegicusPredicted (SEA)267.412
Click to view 3D structureAngiotensin-converting enzymeP12822Oryctolagus cuniculusPredicted (SEA)111.169
Click to view 3D structureD(2) dopamine receptorP61169RatPredicted (SEA)613.218
Solute carrier family 15 member 1 structureClick to view 3D structureSolute carrier family 15 member 1P46059HumansPredicted (SEA)64.4592
Dipeptidyl peptidase 8 structureClick to view 3D structureDipeptidyl peptidase 8Q6V1X1HumansPredicted (SEA)45.5418
Click to view 3D structureNeprilysinP07861Rattus norvegicusPredicted (SEA)144.722
Click to view 3D structureSigma intracellular receptor 2Q5U3Y7Rattus norvegicusPredicted (SEA)290.3
Neprilysin structureClick to view 3D structureNeprilysinP08473HumansPredicted (SEA)170.957
D(2) dopamine receptor structureClick to view 3D structureD(2) dopamine receptorP14416HumansPredicted (SEA)1333.95
Click to view 3D structureKappa-type opioid receptorP41144Cavia porcellusPredicted (SEA)422.332
D(3) dopamine receptor structureClick to view 3D structureD(3) dopamine receptorP35462HumansPredicted (SEA)1210.56
Dipeptidyl peptidase 4 structureClick to view 3D structureDipeptidyl peptidase 4P27487HumansPredicted (SEA)118.331
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available